[Paper Review] Cerebral oxygen extraction fraction MRI: techniques and applications

Dengrong Jiang, Hanzhang Lu|arXiv (Cornell University)|Feb 3, 2022

Advanced MRI Techniques and Applications4 citations

TL;DR

This paper reviews MRI-based techniques for measuring cerebral oxygen extraction fraction (OEF), a key biomarker of brain metabolism and function. It details methods using T2, phase, susceptibility, deoxyhemoglobin effects, and BOLD signal calibration, highlighting their non-invasive, radiation-free advantages over 15O-PET, with applications in neurological disorders.

ABSTRACT

The human brain constitutes 2% of the total body mass, but consumes 20% of the oxygen. The rate of the brain's oxygen utilization can be determined from the knowledge of cerebral blood flow and oxygen extraction fraction (OEF). Therefore, OEF is a key physiological parameter of the brain's function and metabolism. OEF has been suggested to be a useful biomarker in a number of brain diseases. With recent advances in MRI techniques, several MRI-based methods have been developed to measure OEF in the human brain. These MRI OEF techniques are based on T2 of blood, phase of blood signal, susceptibility of blood-containing voxel, effect of deoxyhemoglobin on signal behavior in extravascular tissue, and calibration of BOLD signal using gas-inhalation. Compared to 15O positron emission tomography, which is considered the "gold standard" for OEF measurement, MRI-based techniques are non-invasive, radiation-free, and have broader availabilities. This article provides a review of these emerging MRI-based OEF techniques. We first briefly introduce the role of OEF in brain oxygen homeostasis. We then review the methodological aspects of different categories of MRI OEF techniques, including their signal mechanisms, acquisition methods, and data analyses. Advantages and limitations of the techniques are discussed. Finally, we review key applications of these techniques in physiological and pathological conditions.

Motivation & Objective

• To review emerging MRI techniques for non-invasive measurement of cerebral oxygen extraction fraction (OEF), a critical physiological parameter.
• To compare the signal mechanisms, acquisition protocols, and data analysis methods across different MRI-based OEF techniques.
• To evaluate the advantages and limitations of each MRI OEF method relative to the gold standard 15O-PET.
• To summarize key applications of OEF MRI in physiological and pathological brain conditions.
• To provide a comprehensive overview for researchers in medical physics and neuroscience on current OEF-MRI methodologies and their clinical potential.

Proposed method

• Utilizes T2 relaxation changes in deoxygenated blood to estimate OEF, leveraging susceptibility effects on signal decay.
• Employs phase shifts in the MRI signal caused by deoxyhemoglobin's magnetic susceptibility to quantify OEF.
• Analyzes magnetic susceptibility of blood-containing voxels to infer regional OEF values.
• Models the effect of deoxyhemoglobin on signal behavior in extravascular brain tissue to derive OEF maps.
• Calibrates BOLD signal changes during hypercapnic gas inhalation to estimate baseline OEF without ionizing radiation.
• Compares these MRI-based OEF methods to 15O-PET, the established gold standard, in terms of accuracy, spatial resolution, and clinical feasibility.

Experimental results

Research questions

• RQ1 How do different MRI-based techniques measure cerebral oxygen extraction fraction (OEF) using distinct signal mechanisms?
• RQ2 What are the relative strengths and limitations of each MRI OEF technique in terms of accuracy, resolution, and scan time?
• RQ3 How do MRI-derived OEF measurements compare to those obtained with 15O-PET, the current gold standard?
• RQ4 In what physiological and pathological brain conditions has OEF MRI demonstrated clinical utility?
• RQ5 What are the key methodological challenges in translating OEF-MRI into routine clinical use?

Key findings

• MRI-based OEF techniques offer a non-invasive, radiation-free alternative to 15O-PET for measuring cerebral oxygen metabolism.
• Multiple MRI methods—based on T2, phase, susceptibility, and BOLD calibration—have been developed, each with distinct signal mechanisms and performance trade-offs.
• These techniques enable regional mapping of OEF, providing insights into brain energy metabolism and hypoxic states.
• OEF MRI has shown promise in detecting early metabolic changes in neurological disorders such as stroke, Alzheimer’s disease, and brain tumors.
• Despite progress, challenges remain in standardization, quantification accuracy, and clinical translation due to physiological and sequence-dependent variability.
• The review establishes a foundation for future development of OEF-MRI as a clinically viable biomarker in neurology and neuroscience.